You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Baxter
Johnson and Johnson
Colorcon
Medtronic

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018677


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 018677 describes CESAMET, which is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. Additional details are available on the CESAMET profile page.

The generic ingredient in CESAMET is nabilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nabilone profile page.
Summary for 018677
Tradename:CESAMET
Applicant:Bausch
Ingredient:nabilone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018677
Suppliers and Packaging for NDA: 018677
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CESAMET nabilone CAPSULE;ORAL 018677 NDA Bausch Health US LLC 0187-1231 0187-1231-50 1 BOTTLE in 1 CARTON (0187-1231-50) > 50 CAPSULE in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength1MG
Approval Date:Dec 26, 1985TE:RLD:Yes

Expired US Patents for NDA 018677

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985   Start Trial   Start Trial
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985   Start Trial   Start Trial
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985   Start Trial   Start Trial
Bausch CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
McKesson
Harvard Business School
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.